Table 3.
Clinical characteristics of participants (N = 25)
| Characteristics | Frequency | Percentage |
|---|---|---|
| Number of aspirations | ||
| 3 | 11 | 44 |
| 2 | 8 | 32 |
| 1 | 6 | 24 |
| Duration of follow-up (resolution time) | ||
| 6 | 4 | 16 |
| 7 | 4 | 16 |
| 8 | 6 | 24 |
| 9 | 7 | 28 |
| 10 | 4 | 16 |
| Continued breastfeeding | ||
| No | 6 | 24 |
| Yes | 19 | 76 |
| Breastfeeding counseling received | ||
| No | 21 | 84 |
| Yes | 4 | 16 |
| Place of antenatal care | ||
| Not in the Douala General Hospital | 16 | 56 |
| Others | 7 | 24 |
| Douala General Hospital | 4 | 4 |
| Past history of mastitis in multiparous women (N = 17) | ||
| No | 12 | 71 |
| Yes | 5 | 29 |
| Type of treatment received | ||
| Flucloxacillin 500 mg + aspiration | 18 | 72 |
| Flucloxacillin 500 mg + aspiration+ infiltration ceftriaxone | 6 | 24 |
| Erythromycin + aspiration | 1 | 4 |
| Gestational age at delivery (weeks) | ||
| 38 | 8 | 32 |
| 39 | 8 | 32 |
| 40 | 4 | 16 |
| 41 | 5 | 20 |